Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pre-emptive Immunosuppression in Lupus Nephritis
NCT04870359Completed
- Sponsor
- The University of Hong Kong
- Start
- Apr 2016
- Primary completion
- Mar 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of prednisolone, azathioprine and mycophenolate mofetil in lupus nephritis (LN) (2 arms), sponsored by The University of Hong Kong. Primary endpoint: Renal Flare at 24 months. Started Apr 2016; status: completed.
02
Drugs
prednisoloneazathioprinemycophenolate mofetil
03
Conditions
lupus nephritis (LN)
Beyond the preview
Go deeper on NCT04870359.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04870359.